During the past decade, National Hospital Organization Kyushu Cancer Center conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 20 clinical trials were completed, i.e. on average, 48.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 13 clinical trials were completed. i.e. 72.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Kyushu Cancer Center" #1 sponsor was "Pfizer" with 9 trials, followed by "Amgen" with 8 trials sponsored, "Boehringer Ingelheim" with 8 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored and "Incyte Corporation" with 6 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kyushu Cancer Center" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Korean Cancer Study Group" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Astellas Pharma Inc" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kyushu Cancer Center" are "Breast Cancer" (6 trials), "Gastric Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Gastroesophageal Junction Adenocarcinoma" (3 trials) and "Adult T-cell Leukemia-Lymphoma" (2 trials). Many other conditions were trialed in "National Hospital Organization Kyushu Cancer Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Kyushu Cancer Center" are "Drug" (63 trials), "Biological" (9 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Docetaxel" (8 trials), "Paclitaxel" (5 trials), "Trastuzumab" (4 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Kyushu Cancer Center" are 59 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "National Hospital Organization Kyushu Cancer Center". undefined are not yet recruiting, 7 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in National Hospital Organization Kyushu Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Kyushu Cancer Center, 7 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".